Effectiveness of Port Site Bupivacaine Injection in Postoperative Pain Reduction After Lap. Chole

• Status: Not yet recruiting
• Trial end date: 2022-09-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine the effectiveness of port site bupivacaine infiltration in postoperative pain reduction after laparoscopic cholecystectomy.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hamdard University
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

1. Patients of both the gender of age >18 years and <45years

2. Patients undergoing elective laparoscopic cholecystectomy under general anesthesia.

3. Patients with A.S.A grade I and II.

Exclusion Criteria:

1. Patients with known allergic reactions to local anesthetics.

2. Patients converted to open procedure.

3. Patients developing intra-operative complications.

4. Patients undergoing for laparoscopic cholecystectomy for acute cholecystitis.

5. Patients with obesity and chronic illness.

6. Patients with history of opioids, steroids, NSAIDs and alcohol use.